Review
Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder
Affiliations
- PMID: 11762576
- PMCID: PMC81668
Item in Clipboard
Review
Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder
CMAJ.
.
No abstract available
Comment in
-
Treatment of attention-deficit hyperactivity disorder.CMAJ. 2002 May 14;166(10):1251-2. CMAJ. 2002. PMID: 12041836 Free PMC article. No abstract available.
Comment on
-
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.CMAJ. 2001 Nov 27;165(11):1475-88. CMAJ. 2001. PMID: 11762571 Free PMC article.
-
Prescription of methylphenidate to children and youth, 1990-1996.CMAJ. 2001 Nov 27;165(11):1489-94. CMAJ. 2001. PMID: 11762572 Free PMC article.
Similar articles
-
Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.Nord J Psychiatry. 2009 Nov;63(6):508-16. doi: 10.3109/08039480903154534. Nord J Psychiatry. 2009. PMID: 19958258
-
Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.Curr Med Res Opin. 2010 Nov;26(11):2565-74. doi: 10.1185/03007995.2010.518131. Epub 2010 Sep 23. Curr Med Res Opin. 2010. PMID: 20863165
-
Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.J Atten Disord. 2010 Nov;14(3):267-72. doi: 10.1177/1087054709356386. Epub 2010 May 19. J Atten Disord. 2010. PMID: 20484708
-
Effectiveness outcomes in attention-deficit/hyperactivity disorder.J Clin Psychiatry. 2006;67 Suppl 8:38-45. J Clin Psychiatry. 2006. PMID: 16961429 Review.
-
An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Ann Pharmacother. 2009. PMID: 19470858 Review.
Cited by
-
Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.BMC Res Notes. 2013 Jun 5;6:220. doi: 10.1186/1756-0500-6-220. BMC Res Notes. 2013. PMID: 23734766 Free PMC article.
-
Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United States.Front Psychiatry. 2021 Apr 29;12:640244. doi: 10.3389/fpsyt.2021.640244. eCollection 2021. Front Psychiatry. 2021. PMID: 33995146 Free PMC article.
-
Treatment of attention-deficit hyperactivity disorder.CMAJ. 2002 May 14;166(10):1251-2. CMAJ. 2002. PMID: 12041836 Free PMC article. No abstract available.
-
Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countries.PLoS Med. 2010 Feb 23;7(2):e1000235. doi: 10.1371/journal.pmed.1000235. PLoS Med. 2010. PMID: 20186271 Free PMC article.
-
The clinical impact of switching attention deficit hyperactivity disorder patients from OROS(®)-MPH to Novo-MPH ER-C(®): A paediatric practice review.Paediatr Child Health. 2013 Feb;18(2):70-3. doi: 10.1093/pch/18.2.70. Paediatr Child Health. 2013. PMID: 24421659 Free PMC article.
References
-
- Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 2001; 165(11):1475-88. Available: www.cma.ca/cmaj/vol-165/issue-11/1475.asp - PMC - PubMed
-
- Miller AR, Lalonde CE, McGrail KM, Armstrong RW. Prescription of methylphenidate to children and youth, 1990–1996. CMAJ 2001:165(11): 1489-94. Available: www.cma.ca/cmaj/vol-165/issue-11/1489.asp - PMC - PubMed
-
- Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996;35:409-32. - PubMed
-
- National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000;39(2):182-93. Available: http://odp.od.nih.gov/consensus/cons/110/110_intro.htm (accessed 2001 Oct 17). - PubMed
-
- Agency of Health Care Policy and Research. Treatment of attention deficit/hyperactivity disorder. Rockville (MD): The Agency; 1999. AHCPR Publication no 99-E017. Available: http://www.ahrq.gov/clinic/adhdsum.htm (acessed 2001 Oct 17).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
